Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES CIPLA ALKEM LABORATORIES/
CIPLA
 
P/E (TTM) x 29.3 33.7 86.7% View Chart
P/BV x 4.5 4.1 108.9% View Chart
Dividend Yield % 1.0 0.5 222.8%  

Financials

 ALKEM LABORATORIES   CIPLA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
CIPLA
Mar-22
ALKEM LABORATORIES/
CIPLA
5-Yr Chart
Click to enlarge
High Rs4,0681,083 375.5%   
Low Rs2,671806 331.3%   
Sales per share (Unadj.) Rs889.4269.7 329.7%  
Earnings per share (Unadj.) Rs140.531.7 443.0%  
Cash flow per share (Unadj.) Rs166.044.8 370.7%  
Dividends per share (Unadj.) Rs34.005.00 680.0%  
Avg Dividend yield %1.00.5 190.6%  
Book value per share (Unadj.) Rs722.4257.8 280.2%  
Shares outstanding (eoy) m119.57806.81 14.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.83.5 108.2%   
Avg P/E ratio x24.029.8 80.5%  
P/CF ratio (eoy) x20.321.1 96.2%  
Price / Book Value ratio x4.73.7 127.3%  
Dividend payout %24.215.8 153.5%   
Avg Mkt Cap Rs m402,868762,177 52.9%   
No. of employees `000NANA-   
Total wages/salary Rs m19,62735,299 55.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,342217,633 48.9%  
Other income Rs m1,6273,217 50.6%   
Total revenues Rs m107,968220,851 48.9%   
Gross profit Rs m20,38043,298 47.1%  
Depreciation Rs m3,04010,520 28.9%   
Interest Rs m5241,064 49.2%   
Profit before tax Rs m18,44334,933 52.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6409,338 17.6%   
Profit after tax Rs m16,80325,595 65.7%  
Gross profit margin %19.219.9 96.3%  
Effective tax rate %8.926.7 33.3%   
Net profit margin %15.811.8 134.4%  
BALANCE SHEET DATA
Current assets Rs m84,354147,108 57.3%   
Current liabilities Rs m48,05349,129 97.8%   
Net working cap to sales %34.145.0 75.8%  
Current ratio x1.83.0 58.6%  
Inventory Days Days4263 66.8%  
Debtors Days Days656 1,126.3%  
Net fixed assets Rs m43,245119,415 36.2%   
Share capital Rs m2391,614 14.8%   
"Free" reserves Rs m86,134206,364 41.7%   
Net worth Rs m86,373207,977 41.5%   
Long term debt Rs m944,162 2.3%   
Total assets Rs m127,599266,523 47.9%  
Interest coverage x36.233.8 107.0%   
Debt to equity ratio x00 5.4%  
Sales to assets ratio x0.80.8 102.1%   
Return on assets %13.610.0 135.8%  
Return on equity %19.512.3 158.1%  
Return on capital %21.917.0 129.3%  
Exports to sales %18.726.2 71.4%   
Imports to sales %08.2 0.0%   
Exports (fob) Rs m19,92457,094 34.9%   
Imports (cif) Rs mNA17,803 0.0%   
Fx inflow Rs m19,92460,180 33.1%   
Fx outflow Rs m3,91117,803 22.0%   
Net fx Rs m16,01342,376 37.8%   
CASH FLOW
From Operations Rs m11,11033,259 33.4%  
From Investments Rs m-14,351-18,719 76.7%  
From Financial Activity Rs m3,796-15,998 -23.7%  
Net Cashflow Rs m580-1,323 -43.8%  

Share Holding

Indian Promoters % 57.1 13.5 423.6%  
Foreign collaborators % 0.0 20.1 -  
Indian inst/Mut Fund % 19.8 49.0 40.4%  
FIIs % 5.7 27.6 20.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.9 66.4 64.6%  
Shareholders   84,104 418,910 20.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    AUROBINDO PHARMA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Cipla Share Price Performance

Period ALKEM LABORATORIES Cipla S&P BSE HEALTHCARE
1-Day -0.50% 0.57% -0.46%
1-Month 11.09% 2.62% 0.65%
1-Year -17.79% 10.30% -13.70%
3-Year CAGR 19.17% 33.49% 20.93%
5-Year CAGR 12.21% 13.10% 10.98%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.1% stake in the company. In case of Cipla the stake stands at 33.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

Cipla paid Rs 5.0, and its dividend payout ratio stood at 15.8%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

5 Reasons Why Sensex Plunged 1,021 Points Today(Closing)

After opening the day on a negative note, Indian share markets extended losses as the session progressed and ended deep in the red.